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Epithelial cells of mucosal tissues provide a barrier
against environmental stress, and keratinocytes are
key decision makers for immune cell function in the
skin. Currently, epithelial signaling networks that
instruct barrier immunity remain uncharacterized.
Here we have shown that keratinocyte-specific
deletion of a disintegrin and metalloproteinase
17 (Adam17) triggers T helper 2 and/or T helper 17
(Th2 and/or Th17) cell-driven atopic dermatitis and
myeloproliferative disease. In vivo and in vitro defi-
ciency of ADAM17 dampened Notch signaling,
increasing production of the Th2 cell-polarizing
cytokine TSLP and myeloid growth factor G-CSF.
Ligand-independent Notch activation was identi-
fied as a regulator of AP-1 transcriptional activity,
with Notch antagonizing c-Fos recruitment to
the promoters of Tslp and Csf3 (G-CSF). Further,
skin inflammation was rescued and myeloprolifera-
tion ameliorated by delivery of active Notch to
Adam17/ epidermis. Our findings uncover an
essential role of ADAM17 in the adult epidermis,
demonstrating a gatekeeper function of the
ADAM17-Notch-c-Fos triad in barrier immunity.
INTRODUCTION
Inflammatory skin diseases afflict more than 10% of people in
the western world (Bieber, 2008). Keratinocytes are the predom-
inant epithelial cell type that generates the epidermal layer of the
skin. The onset of epidermal inflammation represents a collapse
of epithelial homeostasis resulting in the generation of alarm
signals by keratinocytes. This in turn recruits the immune system
to eliminate infected and/or damaged cells and restore homeo-
stasis. Factors produced by epithelial cells that guide immune
cell functions are being recognized as the ‘‘epimmunome’’ and
it is important to elucidate the mechanisms that underpin their
synthesis. Stress response pathways (e.g., NF-kB, AP-1) have
emerged as key junctions in the maintenance of epithelial cell
homeostasis (Swamy et al., 2010). Disruption of either develop-mental programming or induction of physiological stress in ker-
atinocytes that compromises barrier function leads to copious
production of alarmins including thymic stromal lymphoprotein
(TSLP) and interleukin 33 (IL-33), as well as hematopoietic
growth factors such as granulocyte colony stimulating factor
(G-CSF) or granulocyte macrophage colony stimulating factor
(GM-CSF). Over time these generate atopic dermatitis by
TSLP-mediated activation of dermal dendritic cells, which
results in a local cellular immune response (Demehri et al.,
2009; Ziegler and Artis, 2010). Additionally, increased production
of myeloid growth factors by keratinocytes has been shown to
be causal to the development of myeloproliferative disease
(MPD) in mouse models of inflammatory skin disease (Dumortier
et al., 2010; Meixner et al., 2008). Therefore, keratinocytes in
the epidermis direct local immunity and hematopoietic develop-
ment, yet epithelial signaling networks that instruct the epimmu-
nome are poorly defined.
The Notch pathway is a master regulator of cell fate decisions
and has established roles in directing differentiation of all cell
layers in metazoans. Recent emerging evidence also supports
a role for this pathway in the maintenance of adult tissue homeo-
stasis. In epithelial tissues such as the skin, Notch signaling
sustains the epidermal barrier by promoting cell-autonomous
keratinocyte terminal differentiation (Blanpain et al., 2006).
Importantly, it also orchestrates communication between the
epithelial and immune compartments of the skin to prevent
chronic inflammation. For example, recent studies of Notch in
adult tissue homeostasis have highlighted its requirement in
preventing inflammatory skin disease (Dumortier et al., 2010;
Goud and Deshpande, 2011); however, the molecular mecha-
nisms by which epithelial Notch performs this immunoregulatory
function remain elusive.
A disintegrin and metalloproteinase 17 (ADAM17), also called
TNF alpha converting enzyme (TACE), is a transmembrane
metalloproteinase that cleaves cell surface proteins (Blobel,
2005; Murphy et al., 2008). It is essential for postnatal survival
in mice and is implicated in immune cell development and
function (Horiuchi et al., 2007; Li et al., 2007a, 2007b). ADAM-
mediated shedding of Notch receptors (termed S2 cleavage) is
a key step in activating Notch signaling, but to date only
ADAM10 has been shown to perform this action in vivo, as
demonstrated by its role in marginal zone B cell development
(Gibb et al., 2010). ADAM10 also performs S2 cleavage of Notch
in keratinocytes, and epidermal ADAM10 deficiency leads toImmunity 36, 105–119, January 27, 2012 ª2012 Elsevier Inc. 105
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relevance of ADAM17 in epithelial:immune crosstalk is unknown.
We investigated this by inactivating Adam17 in the epidermis of
adult mice. The main outcomes were spontaneous onset of
atopic dermatitis (AD) and myeloproliferative disease (MPD).
Keratinocyte-specific deletion of Adam17 triggered sponta-
neous peripheral accumulation of T helper 2 (Th2), Th17, and
gd T cells, dermal mast cell infiltration, and elevated serum IgE.
In parallel, an increase in Gr-1+CD11b+ cells and concomitant
loss of B220+ B lymphocytes was observed in the bone marrow.
By using in vivo and in vitro approaches, we found that ADAM17
is crucial for basal Notch activation in adult epidermis and
that ectopic Notch activation was sufficient to rescue local skin
inflammation and MPD in mutant mice. We further identified
elevated activator protein-1 (AP-1) transcriptional activity as
causal to TSLP and G-CSF production. Analysis of signal
crosstalk between Notch and AP-1 pathways in mouse and
human keratinocytes revealed that Notch antagonized c-Fos
recruitment to epithelial cytokine promoters to keep stress
signaling in check. Collectively, our results demonstrate that
ADAM17 permits tonic Notch activation in the adult epidermis
to regulate epithelial cytokine production and maintain barrier
immunity.
RESULTS
Onset of Spontaneous Atopic Dermatitis upon Deletion
of Epidermal Adam17
Keratinocytes comprise the vast cellular majority of the
epidermis. Basal keratinocytes reside at the epidermal-dermal
interface and migrate outward toward the skin surface as they
undergo terminal differentiation. We induced Adam17 deletion
in basal keratinocytes by breeding Adam17fl/fl and Krt14-cre
transgenic mice expressing the cre recombinase under control
of the Keratin14 promoter (Figure 1A). These mice (termed
Adam17Dep) exhibited a progressive atopic-dermatitis-like
inflammatory skin disease with 100% penetrance as early as
3 weeks of age. Hematoxylin and eosin staining showed
epidermal thickening, a loss of subcutaneous fat, and regions
of hyperkeratosis, and immunohistochemical analysis with the
proliferation marker Ki67 revealed keratinocyte hyperprolifera-
tion (Figures 1B and 1C). Histological and FACS analysis
revealed massive infiltration by F4/80+ macrophages (Figures
1D and 1E; FACS quantification in scatterplot to the right) and
Toluidine-B+ mast cells in the dermis (arrows, Figure 1F; quanti-
fication in scatterplot to the right). Consistent with mast cell
influx, serum IgE concentrations were >100-fold higher in
Adam17Dep mice (Figure 1G). We also measured a markedFigure 1. Epidermal ADAM17 Deficiency Causes Atopic Dermatitis
(A) ADAM17 immunoblot performed on tail epidermis and dermis of adult Adam1
(B and C) Histological analysis performed on dorsal skin (B, H&E) and keratinocy
(D and E) Immunohistochemical and flow cytometry (FACS) quantification for F4
(F) Toluidine-B staining performed to measure mast cell infiltration (red arrows),
(G) Serum IgE measured by ELISA.
(H) Serum and tail epidermis analyzed by ELISA for concentrations of TSLP and
(I) Bead array profiling of serum for indicated cytokines.
(J) qPCR analysis of indicated cytokine mRNAs from tail epidermis of Adam17fl/fl
*p < 0.05 mean ± SEM (nR 4). Histology and immunoblotting data are represenincrease in thymic stromal lymphoprotein (TSLP) and inter-
leukin-33 (IL-33), both in the epidermis and systemically (Fig-
ure 1H). These data indicated spontaneous onset of AD in
mice lacking epidermal ADAM17.
The production of Th2 cell cytokines typifies atopic diseases
(Fort et al., 2001). We observed dramatic changes in serum
concentrations of specific factors, most notably the elevation
of Th2 (IL-4, IL-15) and reduction in Th1 (IFN-g, IL-12p40) cell
cytokines in 10-week-old mutant mice (Figure 1I). In addition to
Th2 cell cytokine production, cutaneous mechanical injury
caused by dry, itchy skin is a major contributor to the generation
of IL-17-producing lymphocytes (Jin et al., 2009). The accumula-
tion of IL-17-producing T lymphocytes in peripheral blood also
correlates significantly with disease severity of AD in human
patients (Di Cesare et al., 2008; Koga et al., 2008). Mutant
mice exhibited greater serum concentrations of IL-17A and its
polarizing cytokine IL-6 (Ogura et al., 2008) (Figure 1I). Direct
gene expression analysis of the epidermis showed significantly
higher expression of inflammatory cytokines IL-1b, IL-4, IL-6,
IL-15, and IL-17A and IL-17F in mutant skin. Of note, epidermal
TNFa expression was decreased in ADAM17-deficient skin, and
both IL-12 subunits (IL-12p40 and IL-12p35) were not detected
(Figure 1J). Thus, epidermal Adam17 loss results in a sponta-
neous Th2 or Th17 cell-dominant atopic immune response.
Th2 and Th17 Cell Polarized Cellular Immunity
in Skin-Draining Lymph Nodes of Adam17Dep Mice
In order to characterize the nature and origin of the cellular
immune response, we compared skin-draining (dLN) and
mesenteric (mLN) lymph nodes. Along with obvious lymphade-
nopathy (data not shown), FACS analysis showed a 10-fold
elevation in Gr-1+CD11b+ monocytes and the presence of
CD11c+MHCII+ antigen-presenting cells (APCs) in Adam17Dep
mice (Figures 2A and 2B). Although both CD8+ and CD4+
T lymphocytes were activated in the dLNs of Adam17Dep mice
(histograms, Figure 2C), CD4+ T cell activation was induced to
a much greater magnitude as indicated by the 8-fold higher
numbers of CD4+CD69+ versus CD8+CD69+ T cells (bar graphs,
Figure 2C). Lymphocyte activation follows a shift from naive
(CD62L+CD44) to effector (CD62LCD44+) T cell phenotypes
(Fang et al., 2002). Adam17Dep mice had a 4-fold increase in
CD4+ effector T cells specifically in dLN but not in mLN (Fig-
ure 2D). Next, FACS analysis of phorbol myristate acetate
(PMA)-stimulated lymphocytes obtained from skin-draining
lymph nodes showed a measurable number of CD4+IL-17A+
Th17 cells (Figure 2E) and a large population of gdTCR+IL-17A+
gdT cells in the dLNs of Adam17Dep mice (Figure 2F). These
data confirm the skin-specific origin of cellular immunity in7fl/fl and Adam17Dep mice.
te proliferation (C, Ki67 immunostaining).
/80 to measure macrophage infiltration in dermis.
quantified on the right.
IL-33.
and Adam17Dep mice.
tative of at least six mice. Scale bars represent 100 mm.
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Figure 2. Skin-Specific Lymphocyte Activation and IL-17A Production in Adam17Dep Mice
(A) FACS analysis of macrophage-monocytes (Gr-1+CD11b+) in skin-draining lymph nodes (dLN) and mesenteric lymph nodes (mLN).
(B) FACS analysis of activated (CD11c+MHCII+) dendritic cells in dLNs.
(C) FACS analysis of CD8+ versus CD4+ T cell activation by CD69 staining in mLNs and dLNs. Bar graphs are quantifications of histograms.
(D) Induction of CD4+ effector T cells (CD62LCD44+) in dLNs of Dep mice measured by FACS. Bar graphs are quantifications of indicated populations shown in
representative plots.
(E) Identification of gdTCR+IL-17A+ populations in dLN lymphocytes restimulated ex vivo with PMA+ionomycin in the presence of Brefeldin A. Bar graphs
indicate relative abundance of IL-17A-producing cells.
(F) Analysis of CD3+CD4+IL-17A+ (Th17) cell populations, dLN lymphocytes restimulated as in (E). Bar graph depicts relative abundance of CD3+CD4+IL-17A+
cells.
*p < 0.05 mean ± SEM. Data in (A)–(D) are representative of at least 12 mice. Data in (F) and (G) are representative of 7 mice.
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Th17 cells as the source of IL-17A.
Onset of Severe Myeloproliferative Disease
in Adam17Dep Mice
Mice harboring genetic epidermal defects often exhibit myelo-
proliferative disease (MPD) (Dumortier et al., 2010; Meixner
et al., 2008). Our investigation of Adam17Dep mice revealed
strikingly high concentrations of serum G-CSF along with the
presence of splenomegaly (Figure S1A available online and
data not shown). Interestingly, we noted a severe drop in bone
marrow B220+ lymphocyte populations in Adam17Dep mice,
which upon further characterization were found to be predomi-
nantly naive B lymphocytes expressing high amounts of IgM
compared to controls (Figures S1B and S1C). Although the total
number of bone marrow cells were comparable (data not
shown), Gr-1+CD11b+ myeloid populations were proportionally
higher in bone marrow and spleen of Adam17Dep mice (Fig-
ure S1D), fulfilling all of the hallmarks of MPD (Campbell and
Green, 2006). We postulated that this myeloid cell expansion
contributed to higher IL-12p70 concentrations observed in the
serum of Adam17Dep mice (Figure 1I) and assayed the capacity
of spleen and bone marrow cells to produce IL-12p70 or
IL-12p40. Stimulating total spleen and bone marrow cells
ex vivo with LPS in the presence of IFN-g resulted in markedly
greater IL-12p70 production by cells obtained from Adam17Dep
mice (Figure S1E). IL-12p40 concentrations were lower in the
serum and in unstimulated (basal) cultures of spleen cells ob-
tained from Adam17Dep mice (Figures 1J and S2G). LPS+IFN-g
stimulation induced IL-12p40 production ex vivo, indicating
that epidermal ADAM17 deficiency did not compromise cell-
autonomous capacity to produce IL-12p40 (Figure S1F). These
data demonstrate that epidermal ADAM17 deficiency is suffi-
cient to induce the expansion of IL-12p70-producing myeloid
cells in mice.
TNFR1 Signaling Is Dispensable for Atopic Dermatitis
and Myeloproliferative Disease in Adam17Dep Mice
TNF inhibitors have had measurable success in therapy of
inflammatory skin disease in humans (Guinea-Viniegra et al.,
2009; Leung et al., 2004; Pasparakis et al., 2002). Independent
genetic models show that psoriasis-like inflammatory skin
disease caused by epidermal loss of Ikkb or Jun and Junb is
ameliorated by the deletion of TNF receptor 1 (Tnfr1), but the
importance of TNFR1 signaling in models of atopic dermatitis
has not been tested. ADAM17 is the most relevant sheddase
for the cleavage of membrane-bound TNF and its receptors,
and we have previously shown that regulation of ADAM17
activity by its endogenous inhibitor TIMP3 provides a critical
axis of control over TNF in models of acute and chronic hepatic
inflammation (Mohammed et al., 2004; Murthy et al., 2010;
Smookler et al., 2006). Therefore, we bred Adam17Dep mice
into a Tnfr1-deficient background and surprisingly found that
Tnfr1 loss failed to rescue epidermal inflammation. Analyses of
peripheral immunity demonstrated activation of CD4+ T cells
(Figure S2A), induction of CD4+ effector T cells (Figure S2B),
and elevated major histocompatibility complex class II (MHCII)
expression on APCs in dLN of Adam17DepTnfr1/ mice (Fig-
ure S3C). Adam17DepTnfr1/ mice also exhibited MPD, withincreased proportions of Gr-1+CD11b+ myeloid cells and a loss
of B220+ B lymphocytes in the bone marrow (Figures S2D and
S2E). Thus, epidermal ADAM17 prevents atopic dermatitis and
maintains bone marrow homeostasis independent of TNFR1
signaling.Precocious Differentiation of ADAM17-Deficient
Keratinocytes In Vivo and In Vitro
ADAMs perform ectodomain shedding of several factors
required for keratinocyte development including epidermal
growth factor receptor (EGFR) ligands and Notch. For example
ADAM17 cleaves a subset of EGFR ligands whereas ADAM10
is the recognized metalloproteinase for Notch processing. The
epidermal loss of Adam10 was recently reported to impair kera-
tinocyte differentiation in mice; they failed to establish the
spinous layer of the epidermis (Weber et al., 2011). We therefore
asked whether the observed epidermal inflammation arose
because of incomplete keratinocyte differentiation. This was
not the case for Adam17Dep mice; immunofluorescence staining
of the skin showed comparable establishment of terminal kerati-
nocyte differentiation measured by basal (Keratin 5), early
(Keratin10), and late (Filaggrin) markers (Figure 3A). Further,
gene expression analysis confirmed the presence of basal and
spinous (early) lineages along with increased expression of
granular (late) lineage markers in the epidermis of newborn
Adam17Dep mice (Figure 3B). We next created cell-autonomous
ex vivo deletion of Adam17 with Adam17fl/fl keratinocytes
transduced with adenoviral Cre (termed AdCre-Adam17/),
and we tested the differentiation capacity of these cells by using
an established method of inducing terminal differentiation, i.e.,
increasing extracellular concentrations of calcium to >1.0 mM.
AdCre-Adam17/ keratinocytes exhibited accelerated differ-
entiation as measured by gene expression of basal, early
(spinous), and late (granular or cornified) markers (Figure 3C).
Of note, adenoviral deletion of Adam17 induced precocious
keratinocyte differentiation even in basal conditions (AdCre
Low Ca2+ group, Figure 3C). Consistent with the onset of
terminal differentiation, AdCre-Adam17/ keratinocytes prolif-
erated at a slower rate in basal conditions when compared
with control (AdGFP) keratinocytes (Figure 3D). These data
indicate that in contrast to ADAM10 deficiency, loss of
Adam17 leads to precocious keratinocyte differentiation in a
cell-autonomous manner.Inducible Deletion of Epidermal Adam17 in Adult Mice
Recapitulates Atopic Dermatitis and Myeloproliferative
Disease
Beyond keratinocyte differentiation, we reasoned that ADAM17
would be required for epidermal homeostasis in the adult skin.
We therefore bred Adam17fl/fl mice with transgenic mice ex-
pressing tamoxifen-inducible cre-recombinase under control of
the Krt14 promoter (termed Adam17DepERT mice) and induced
Adam17 deletion as outlined in Figure 4A. Mice were analyzed
at early (3 month) and late (8 month) time points postdeletion.
Tamoxifen-induced deletion of Adam17 resulted in lymphade-
nopathy (data not shown) and skin inflammation. We observed
epidermal thickening (H&E, Figure 4B) and keratinocyte hyper-
proliferation as measured by Ki67 staining as early as 3 monthsImmunity 36, 105–119, January 27, 2012 ª2012 Elsevier Inc. 109
Figure 3. Precocious Differentiation in Adam17Dep Epidermis
(A) Histological (immunofluorescence) analysis of skin at indicated postnatal ages (P) measuring expression of basal marker Keratin5 (K5, green), early differ-
entiation marker Keratin10 (K10, red), and late differentiation marker Filaggrin (Fil, red).
(B) qPCR analysis of basal, early, and late differentiation markers in newborn mice (postnatal day1, P1).
(C) qPCR analysis of keratinocyte differentiation markers in primary keratinocytes after calcium-induced terminal differentiation. Cells were maintained in basal
medium (low Ca2+) or treated with 2 mM calcium (high Ca2+) for 48 hr. AdGFP (control): Adam17fl/fl keratinocytes transduced with adenoviral-GFP; AdCre
(Adam17 deleted): Adam17fl/fl keratinocytes transduced with adenoviral-Cre to induce cell-autonomous Adam17 deletion.
(D) Decreased rate of proliferation in AdCre-Adam17/ keratinocytes cultured in basal conditions.
*p < 0.05, mean ± SEM (n = 4 for B, n = 3 for C and D). Images are representative of at least four mice per genotype. Scale bars represent 50 mm. All data are
representative of two independent experiments.
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cells (arrows, Figure 4D).
FACS analysis indicated higher numbers of CD4+CD69+
activated T cells in dLNs of Adam17DepERT mice (Figure 4E,
quantified in Figure 4F). Additionally, a significantly higher
proportion of CD4+CD62LCD44+ effector T cells was observed
in dLNs of Adam17DepERT mice at all ages (Figure 4G, quantified
in Figure 4H). Finally, these mice developed MPD as character-
ized by loss of B220+ B lymphocytes (Figures S3A and S3B)
and proportionally greater populations of Gr-1+CD11b+ macro-110 Immunity 36, 105–119, January 27, 2012 ª2012 Elsevier Inc.phage-monocytes in bone marrow and spleen (Figures S3C
and S3D). These experiments establish that deletion of
epidermal Adam17 in the adult skin compromises barrier immu-
nity and results in myeloproliferative disease.
Loss of Adam17 Compromises Tonic Notch Signaling
in the Epidermis
Remarkably, Adam17Dep mice closely phenocopy the onset of
AD andMPD previously illustrated upon inducible and combined
postnatal deletion of epidermal Notch1 and Notch2 (Dumortier
Figure 4. Inducible Deletion of Epidermal Adam17 in Adult Mice Recapitulates Atopic Dermatitis and Skin-Specific CD4+ Lymphocyte Acti-
vation
(A) Schematic depicting protocol for tamoxifen treatment and mouse analysis.
(B–D) Histological analysis of dorsal skin by H&E staining (B) Ki67 immunostaining depicting basal keratinocyte proliferation (C) and mast cell influx (D, arrows)
shown by Toluidine B staining.
(E and F) FACS plots and quantification of CD8+ and CD4+ T cell activation in mesenteric lymph nodes (mLN) and skin-draining lymph nodes (dLN) measured by
cell surface CD69.
(G and H) FACS plots and quantification of CD8+ and CD4+ effector T cells identified as CD62LCD44+ populations in mLNs and dLNs of Adam17fl/fl and
Adam17DepERT mice.
*p < 0.05, mean ± SEM (n = 4).
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Figure 5. ADAM17 Provides Ligand-Independent Notch Signaling and Suppresses c-Fos Activity in Keratinocytes
(A) Immunoblot depicting loss of NICD production in adult Dep epidermis.
(B) qPCR analysis of newborn (P1) epidermis for Notch target genes Hes1, Hes5, Hey1, and Hey2.
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ADAM17-Notch-c-Fos Triad Regulates Barrier Immunityet al., 2010). However, there is no physiological evidence for
ADAM17-mediated Notch activation in mammals. We tested
whether ADAM17-deficient skin had defective Notch signaling
and foundNotch intracellular domain (NICD) to be absent in adult
Adam17Dep epidermis (Figure 5A). Moreover, the expression of
multiple Notch target genes was diminished in Adam17Dep
epidermis (Figure 5B). Typically, Notch activation follows ligand
binding (Delta-like 1, 3, 4, Jagged 1, 2) and involves metallopro-
teinase (ADAM)-mediated S2 cleavage of the receptor at the cell
surface with subsequent NICD release via g-secretase (S3
cleavage) (Artavanis-Tsakonas et al., 1999). Notch activation
can occur in a ligand-dependent or ligand-independent manner,
and different groups have shown that ADAM10, but not
ADAM17, is required for ligand-dependent Notch activation
in vitro (Bozkulak and Weinmaster, 2009; Gibb et al., 2010). To
delineate how ADAM17 contributed to Notch activation in
keratinocytes, we examined both possible scenarios for Notch
activation by using AdCre-Adam17/ keratinocytes. In a
ligand-independent model of Notch activation introduced by
Rand et al. (2000), ethylene diamine tetraacetic acid (EDTA)
treatment of AdCre-Adam17/ keratinocytes failed to produce
NICD or induce Notch target gene expression (Figures 5C and
5D). We next measured specific generation of the ADAM-depen-
dent S2 fragment of Notch by adding the g-secretase inhibitor
DAPT in EDTA-treated keratinocyte cultures. Control (AdGFP)
keratinocytes were able to produce both S2 and S3 fragments
of Notch after EDTA treatment, and presence of DAPT ablated
S3 but not S2 cleavage (Figure S4A). Consistent with the
stepwise requirement of S2 Notch cleavage to generate NICD,
AdCre-Adam17/ keratinocytes failed to produce either frag-
ment (Figure S4A). Notch signaling in keratinocytes can also be
induced by increased calcium exposure (Blanpain et al., 2006).
Prolonged treatment with R1 mM calcium resulted in NICD
generation and Notch signaling by control (AdGFP) keratino-
cytes, but AdCre-Adam17/ cells were defective in this model
of Notch signaling as well (Figures S4B and S4C). On the other
hand, ADAM17 was dispensable for ligand-dependent Notch
signaling when induced by Fc-Delta-like 4 fusion protein (Fig-
ure 5E). Decreased gene expression of Adam10, Notch recep-
tors, or the presenilin g-secretases could contribute to the
dampened Notch activation observed in Adam17Dep mice.
Quantitative polymerase chain reaction (qPCR) analysis of the
epidermis showed comparable transcript amounts of Adam9,
10, 12, Notch1, 2, 3, 4, or Psen1 and 2 (Figure S4D). Together,
these data demonstrate that ADAM17 activity is required for(C) Immunoblot depicting a lack of S3 cleavage in AdCre-Adam17/ keratinocy
(D) qPCR measurement of Notch target gene expression (Hes1, Hey2) induced b
(E) qPCR of Notch target gene expression in AdGFP-control and AdCre-Ada
4 (hFc-DLL4).
(F) Analysis of published microarray gene expression data sets indicates differe
psoriasis patients compared to normal controls.
(G) Immunoblotting for NICD, c-Fos, and FRA1 in HaCaT cells pretreated with ADA
for the indicated time points.
(H and I) qPCR measurement of TSLP and CSF-3 (G-CSF) gene expression in H
(J and K) HaCaT cells were pretreated with DMSO (control) or the ADAM17 inhibi
precipitated with the indicated antibodies. Tslp andCsf3 promoters were amplified
AP-1 binding sites (TRE), Notch binding sites (RBP-jk), and primer design (red ar
*p < 0.05 mean ± SEM (n = 4 for B, n = 3 for D, E, H, I). Data in (C)–(E) are rep
independent experiments.Notch signaling in adult skin and suggest that ADAM17 activates
Notch in a ligand-independent manner in keratinocytes.
We further sought evidence for compromised Notch sig-
naling in patients with inflammatory skin disease by using
published microarray human gene expression data sets
(Guttman-Yassky et al., 2009; Nair et al., 2009; Olsson et al.,
2006; Reischl et al., 2007). We consistently observed genes
in the Notch pathway to be differentially expressed in patients
with AD, atopic eczema, and psoriasis (Figure 5F and data not
shown). Specifically, a decrease in Notch2, Notch3, and
Presenilin1 mRNA in AD was observed compared to normal
skin (Figure 5F; gene lists in Table S1). Of note, Adam10 and
Adam17 mRNA displayed a heterogeneous expression pattern
in AD skin, probably because of the pleiotropic functions of
these metalloproteinases. We also performed unsupervised
clustering analysis and observed that genes in the Notch
signaling module stratified AD samples away from psoriasis
and normal samples, suggesting that Notch signaling is more
deregulated in AD than in psoriasis (Figure S4E). The above
data propose a link between ADAM17 and Notch signaling in
human atopic skin disease.
Active Notch Antagonizes c-Fos-Mediated
Transcription of TSLP in Human Keratinocytes
Our next goal was to identify the mechanism by which ADAM17-
driven Notch activation keeps epithelial inflammation in check.
Epithelial cytokines TSLP and IL-33 have emerged as key
alarmins in barrier immunity (Demehri et al., 2009; Saenz et al.,
2008; Ziegler and Artis, 2010). Keratinocytes also produce large
amounts of hematopoietic growth factors CSF-3 (G-CSF) and
CSF-2 (GM-CSF) in an AP-1-regulated manner (Eferl and Wag-
ner, 2003; Meixner et al., 2008). The AP-1 family has pleiotropic
functions in stress response where specific members dimerize,
bind to target sequences, and regulate gene expression (Eferl
and Wagner, 2003). Meanwhile, Notch has been proposed
to inhibit AP-1 activity in vitro (Chu et al., 2002; Talora et al.,
2002). To interrogate members of the AP-1 transcription factor
family antagonized by Notch, we used primary mouse keratino-
cytes and a human keratinocyte cell line (HaCaT cells). We began
by measuring individual AP-1 proteins (c-Jun, JunB, JunD,
c-Fos, FRA1, FRA2) in HaCaT cells after treatment with the
phorbol ester PMA (an AP-1 agonist) over 6 hr. Of these AP-1
members, c-Fos displayed a distinct profile with its amounts
peaking at 2 hr and rapidly terminating at 3 hr (Figure S5A).
c-Fos typically dimerizes with the Jun proteins (c-Jun, JunB,tes after 5 mM EDTA treatment for the indicated times.
y EDTA treatment for 5 min followed by recovery for 4 hr.
m17/ keratinocytes after ligand-dependent Notch activation by Delta like
ntial expression of genes involved in Notch signaling in atopic dermatitis and
M17 inhibitor TAPI-1 or g-secretase inhibitor DAPT, followed by PMA treatment
aCaT cells treated as in (G).
tor TAPI-1, followed by PMA treatment for the indicated times. Chromatin was
from precipitated DNA. Schematics of human Tslp andCsf3 promoters depict
rows).
resentative of three independent experiments; data in (G)–(K) represent two
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increased in HaCaT cells after PMA stimulation (Figure S5A).
We inhibited either ADAM17 activity or NICD production by
using small molecule inhibitors (TAPI-1 and DAPT, respectively),
and both resulted in a sustained production of c-Fos upon PMA
treatment (Figure 5G). TAPI-1 or DAPT treatment also led to the
depletion of NICD as measured by immunoblotting (Figure 5G).
Notably, c-Fos stabilization or NICD depletion correlated with
elevated TSLP and GM-CSF mRNA transcription as measured
by qPCR (Figures 5H and 5I).
The promoter regions of Tslp and Csf3 contain 12-O-tetrade-
canoylphorbol-13-acetate (TPA) response elements (TRE) that
bind AP-1, and promoter polymorphisms that enhance AP-1
binding are associated with higher susceptibility to bronchial
asthma (Harada et al., 2010). These promoters also harbor
RBP-jk binding sites that recruit the Notch transcriptional
complex (schematics for human promoters shown in Figures
5J and 5K, mouse promoters in Figure S5). We assessed
c-Fos and NICD recruitment to these promoters by chromatin
immunoprecipitation (ChIP) assays. NICD was constitutively
present on the Tslp promoter in HaCaT cells and primary
keratinocytes whereas c-Fos was only recruited at 2 hr after
PMA treatment (Figures 5J, 5K, S5B, and S5C). In HaCaT cells,
inhibition of ADAM17 activity with TAPI-1 depleted NICD
production and abolished its recruitment to the Tslp promoter
while concomitantly prolonging c-Fos binding to this region at
3 hr after PMA treatment (Figure 5J). Similar but not identical
antagonism was observed between NICD and c-Fos at the
Csf3 promoter (Figure 5K). Next, ChIP analysis of mouse Tslp
and Csf3 promoters was performed by qPCR amplification.
AdCre-Adam17/ keratinocytes demonstrated a loss of NICD
recruitment to the recombining binding protein suppressor of
hairless (RBP-jk) binding sites of Tslp and Csf3 (Figures S5B
and S5C). Conversely, PMA stimulation resulted in a 3-fold
increase of c-Fos recruitment to TRE of Tslp andCsf3 promoters
(Figures S5B and S5C). Thus, we show that loss of Notch acti-
vation allows for unchecked c-Fos transcriptional activity in
human and mouse keratinocytes.
Ectopic Notch Rescues the Enhanced AP-1-Driven
Stress Response in ADAM17-Deficient Keratinocytes
We next determined whether tonic Notch activation by
ADAM17 keeps AP-1-dependent cytokine production in check.
Adenoviral Cre-mediated Adam17 deletion in keratinocytes
(AdCre-Adam17/) resulted in spontaneous phosphorylation
of the stress kinase JNK 1 and 2 (Figure 6A). Treatment with
PMA specifically enhanced the protein amounts of c-Fos and
another AP-1 member FRA1 in AdCre-Adam17/ compared
to AdGFP control keratinocytes. Additionally, the DNA binding
activity of AP-1 members was elevated in AdCre-Adam17/
keratinocytes (Figures 6B and 6C). Next, qPCR analysis
showed higher TSLP, CSF-2, CSF-3, and c-Fos expression in
AdCre-Adam17/ keratinocytes after PMA treatment; this
was abrogated by the pan AP-1 inhibitor Tanshinone IIA
(TanIIA) (Figure 6D, black bars; Figure S6A). We noted the
specificity of this response because ADAM17 deficiency did
not alter gene expression of either CSF-1 or IL-33 cytokines
or the other AP-1 members (c-Jun, JunB, JunD, FRA1, FRA2)
(Figure S6A). These data show that the loss of Adam17 results114 Immunity 36, 105–119, January 27, 2012 ª2012 Elsevier Inc.in increased AP-1-driven synthesis of the above epithelial
cytokines.
IL-33 is a nuclear cytokine released upon epithelial stress
and is an early activating signal for mast cells. We and others
have previously demonstrated that epithelial cell survival and
migration depends in part on the availability of growth factors
derived from the EGF family (e.g., amphiregulin, TGF-a, HB-
EGF); ectodomain shedding by ADAM17 regulates the avail-
ability of these ligands (Maretzky et al., 2011; Murthy et al.,
2010; Sibilia et al., 2000; Stoll et al., 2010). More recently, genetic
loss of Adam17 in models of colitis has revealed its requirement
in providing EGFR ligands to gut epithelial cells. Mice lacking
epithelial ADAM17 fail to regenerate gut epithelial cells after
injury and consequently succumb to DSS-induced colitis
because of a lack of EGFR ligands (Brandl et al., 2010; Chalaris
et al., 2010). We reasoned that ADAM17-deficient keratinocytes
may have impaired EGFR activation and will exhibit enhanced
stress-induced synthesis of IL-33. High concentrations of
PMA induced IL-33 transcription, and this was enhanced in
AdCre-Adam17/ keratinocytes (Figure S6B). The addition of
soluble EGF suppressed IL-33 transcription, whereas pretreat-
ment with the EGFR receptor tyrosine kinase inhibitor Erlotinib
enhanced its transcription even in control keratinocytes (Fig-
ure S6B). These data suggest that ADAM-mediated ectodomain
shedding may suppress synthesis of specific alarmins by
providing epithelial growth factors.
Wemeasured AP-1 activity in an independent cell type (mouse
embryonic fibroblasts, MEFs) and observed that Adam17/
MEFs had higher basal AP-1 luciferase reporter activity. This
was enhanced after PMA treatment and reduced by a c-Fos
inhibitor (T-5224) (Figure 6E). More importantly, transduction of
active Notch (AdNICD) in AdCre- Adam17/ keratinocytes
ablated the expression of CSF-2, CSF-3, and TSLP (Figure 6F,
black bars; Figure S6C). In addition, AdNICD abolished both
basal and PMA-induced AP-1 luciferase reporter activity in
Adam17/ MEFs (Figure 6E). We therefore conclude that
ADAM17-dependent Notch activation inhibits AP-1 transcrip-
tional activity, with c-Fos being a relevant AP-1 candidate.
Adenoviral Delivery of Active Notch Rescues Local
Cellular Immunity and Myeloproliferation
in Adam17Dep Mice
Finally, to test whether Notch could protect Adam17Dep mice
from AD, we utilized a protocol to induce ectopic Notch activity
in ADAM17-deficient epidermis (schematic in Figure 7A).
Adenoviral delivery of active Notch (AdNICD) into Adam17Dep
mice showed a measurable increase in Notch target gene
expression by qPCR analysis of epidermal scrapings (Fig-
ure 7B). Importantly, CD4+ T cell activation was abrogated in
dorsal dLNs and a loss of effector CD4+ T cells was observed
in AdNICD-treated mice (Figures 7C and 7D). Dorsal delivery of
AdNICD also partially rescued MPD, resulting in a decrease
in bone marrow Gr-1+CD11b+ cells (Figure 7E). More
importantly, a replenishment of B220+ lymphocytes was seen
in AdNICD-treated mice (2.93% in AdGFP versus 13.47% in
AdNICD, Figure 7F). Thus, active Notch was sufficient to rescue
AD as well as MPD in Adam17Dep mice. Altogether these data
show that ADAM17 activates Notch and this in turn interferes
with c-Fos recruitment to the Tslp and Csf3 promoters to
Figure 6. Diminished Notch Activation upon ADAM17 Deficiency Enhances c-Fos-Driven Stress Signaling in Keratinocytes
(A) Immunoblotting detects spontaneous JNK phosphorylation in AdCre-Adam17/ keratinocytes.
(B) Elevated protein amounts of c-Fos and FRA1 in AdCre-Adam17/ keratinocytes after PMA treatment.
(C) Enhanced AP-1 transcription factor binding for specific members of AP-1 family in AdCre-Adam17/ keratinocytes treated with 10 ng/ml PMA for 3 hr.
(D and F) qPCR analysis of CSF-3, TSLP, and c-fos gene expression in keratinocytes 3 hr after PMA treatment. Presence of the pan AP-1 inhibitor Tanshinone IIA
(TanIIA, D) or ectopic expression of active Notch (AdNICD, F) abrogates gene expression.
(E) Measurement of AP-1 luciferase reporter activity in MEFS after 8 hr of PMA treatment. Use of a specific c-Fos inhibitor (T-5224) or ectopic Notch (AdNICD)
abolishes AP-1 luciferase activity.
*p < 0.05, mean ± SEM (n = 3). Data in (A)–(C) are representative of two independent experiments. Data in (D) and (E) are representative of three independent
experiments.
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Figure S6D).
DISCUSSION
We have shown that ADAM17 provides an inherent permissive
signal for basal Notch activation throughout adult life. It triggers
Notch signaling to regulate c-Fos activation, therebymaintaining
epidermal barrier homeostasis. Loss of this control induces the
production of cytokines or alarmins, which catalyze local and
systemic immune responses even in the absence of an overt
exogenous stress. Independent studies have shown that theloss of Notch, deregulation of AP-1, or overproduction of
epithelial TSLP result in inflammatory skin disease (Demehri
et al., 2009; Dumortier et al., 2010; Meixner et al., 2008; Zenz
et al., 2005). The ADAM17-Notch-c-Fos triad uncovered in
our study reveals a mechanistic underpinning of all these
observations.
To date, studies of ADAM10-deficient mice have established
its importance in Notch activation during development (Esteve
et al., 2011; Gibb et al., 2010, 2011; Weber et al., 2011). On the
other hand, the large majority of reported ADAM17-dependent
phenotypes revolve around TNFR or EGFR signaling (Blobel,
2005; Guinea-Viniegra et al., 2009; Horiuchi et al., 2007;Immunity 36, 105–119, January 27, 2012 ª2012 Elsevier Inc. 115
Figure 7. Ectopic Notch Activity Rescues Atopic Dermatitis and Myeloproliferative Disease in Adam17Dep Mice
(A) Experimental protocol to reintroduce active Notch in dorsal skin of Dep mice by subcutaneous delivery of adenoviral vector harboring NICD (AdNICD).
(B) qPCR analysis of Notch target genes Hes1 and Herp1 in dorsal epidermis at experimental endpoint. Bars depict mean expression (n = 4).
(C and D) FACS analysis of dorsal dLNs tomeasure CD4+ T cell activation by cell surface CD69 (C) and CD4+CD62LCD44+ effector T cells (D) inDepmice treated
with AdGFP or AdNICD.
(E and F) FACS analysis of bone marrow Gr-1+CD11b+ cells (E) and B220+ cells (F) in Dep mice treated with AdGFP or AdNICD.
*p < 0.05 mean ± SEM (n = 4 for A, B; n = 3 for C–E). Data in (C)–(E) are representative of three independent experiments. Flow cytometry plots represent four
mice per condition.
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ADAM17-Notch-c-Fos Triad Regulates Barrier ImmunityMaretzky et al., 2011; Mohammed et al., 2004; Murthy et al.,
2010). Recent in vitro studies have brought to light the require-
ment of ADAM17 in ligand-independent Notch activation
(Bozkulak and Weinmaster, 2009; van Tetering et al., 2009).
Our study proposes that ligand-independent Notch signaling
controls barrier immunity but not keratinocyte development.
The developmental context of Notch activation may be fulfilled
by ADAM10, because mice lacking epidermal Adam10 fail to
establish a spinous layer of the epidermis (Weber et al.,
2011), whereas Adam17Dep mice exhibit precocious keratino-
cyte differentiation. Epidermal homeostasis balances cell-
autonomous keratinocyte development and nonautonomous
communication between epithelial, stromal, and immune
compartments in the skin. By generating inducible deletion of
epidermal Adam17 at 8 weeks of age, we have demonstrated
the significance of ADAM17 in maintaining proper epithelial:
immune crosstalk in the adult skin.
In addition to the established role of Notch activation in
keratinocyte development and transformation, it is now
accepted that Notch activation keeps the epidermal stress116 Immunity 36, 105–119, January 27, 2012 ª2012 Elsevier Inc.response in check (Nicolas et al., 2003; Williams et al., 2011).
Accumulating evidence suggests that Notch promotes NF-kB
signaling but inhibits AP-1 activity; both of these pathways
are key components of stress signaling in keratinocytes
but the molecular mechanism by which Notch and AP-1 path-
ways crosstalk have remained elusive (Chu and Bresnick, 2004;
Chu et al., 2002; Meixner et al., 2008; Pasparakis et al., 2002;
Zenz et al., 2005). Although we did not observe defects in
NF-kB signaling (data not shown) or rescue AD through Tnfr1
deletion, we elucidated how ADAM17-dependent Notch
activation prevents spontaneous AP-1 activation and atopic
immunity. Further, the data mining performed in this study
indicated a clear deregulation of the Notch pathway in human
atopic dermatitis. Supporting our findings, polymorphisms
have been reported in patients where enhanced AP-1 recruit-
ment to Tslp and Il4 promoters occurs in several human
atopic diseases (Harada et al., 2010; Pastore et al., 2000;
Song et al., 1996). More recently, a clinical report has identified
that loss-of-function mutations in human Adam17 lead to
spontaneous inflammatory skin disease with a similar etiology
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ADAM17-Notch-c-Fos Triad Regulates Barrier Immunityto that of Adam17Dep mice (Blaydon et al., 2011). Our
study provides a mechanistic explanation for the development
and progression of epidermal inflammation observed in
humans.
It is important to note that additional Notch-dependent
and -independent pathways are probably involved in regulating
epithelial cytokine synthesis in this model. Although our findings
present an antagonistic interplay between active Notch and
c-Fos on cytokine promoters, it is known that the Notch target
gene Hes1 acts as a bona fide transcriptional repressor in
epidermal development (Moriyama et al., 2008). Because we
noted decreased Hes1 gene expression in ADAM17-deficient
epidermis and in primary keratinocytes, it is possible that
a loss of Hes1-mediated suppression contributes to increased
TSLP or G-CSF production. Finally, we and others show that
c-Fos promotes its own transcription (Figure 6D). The loss of
epidermal Adam17 could thus result in a positive feedback
loop wherein accumulating c-Fos transcribes itself, culminating
in undesired epithelial cytokine synthesis.
Epithelial cells are now recognized as orchestrators of the
peripheral immune response, and several recent studies have
identified epithelial mutations causal to undesired immune cell
activation in barrier tissues (Biton et al., 2011; Islam et al.,
2011; Pasparakis, 2009; Swamy et al., 2010). We have demon-
strated a gatekeeper function of ADAM17 in the skin, which
may apply to other mucosal tissues including gut, lung, and
vaginal epithelium. The observation that epidermal ADAM17
suppresses the accumulation of IL-17-producing lymphocytes
(both gd T cells and Th17 T cells) has implications for the treat-
ment of acute dermatitis, because rising IL-17 amounts strongly
correlate with severity of AD in human patients (Di Cesare et al.,
2008; He et al., 2007; Koga et al., 2008). The epimmunome
continues to grow and understanding the mechanisms that
instruct pro- or anti-inflammatory epithelial cytokine synthesis




Adam17fl/fl micewere generated byC.P. Blobel and backcrossed >9 times into
the C57BL/6 background. Krt14-cre transgenic mice (Tg(Krt14-cre)1Amc/J)
and Tnfr1/ mice (C57BL/6-Tnfrsf1atm1Imx/J) were originally obtained from
Jackson laboratories. Krt14-cre mice were crossed with wild-type C57BL/6
mice and maintained as single-hemizygous genotypes harboring a single cre
allele. Epidermal Adam17 deletion was created by generating Krt14-cre;
Adam17fl/fl mice harboring a single cre allele. Adam17fl/fl mice were used as
control genotypes as loss of a single Adam17 allele (Krt14cre;Adam17fl/+
mice) resulted in an intermediate phenotype (data not shown). For tamox-
ifen-induced deletion of Adam17 in Krt14-CreER;Adam17fl/fl mice, tamoxifen
(Sigma, T5648) was prepared by dissolving in sesame oil and repeated
sonication, and administered intraperitoneally (i.p., 1 mg per in 400 ml oil) to
8-week-old mice for 5 consecutive days. As controls, Adam17fl/fl mice were
treated with tamoxifen. Mice were sacrificed and analyzed 3 or 8 months
after treatment. Mice were fed 5%-fat chow ad libitum and housed and
cared for in accordance with protocols approved by the Canadian Council
for Animal Care and the Animal Care Committee of the Ontario Cancer
Institute.
In Vivo Delivery of Active Notch to Rescue Epidermal Inflammation
Mice aged 14 days were treated with a dorsal subcutaneous injection of 43
109pfu/ml adenovirus encoding active Notch (AdNICD, kindly provided byE. Wagner, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain)
or eGFP (Ad-eGFP, Vector Biolabs) dissolved in 50 ml sterile PBS. This
treatment was administered every 48 hr at P14, P16, P18, and P20. At P21,
mice were sacrificed and tissue harvested for analysis. Notch signaling was
confirmed by qPCR analysis of target genes Hes1 and Herp1 from dorsal
epidermis scrapings. Epidermis was obtained by incubating minced dorsal
skin in Liberase Blendzyme (Roche) for 1 hr at 37C with periodic vortexing.
Isolation and Culture of Primary Keratinocytes
Mouse keratinocytes were obtained from Adam17fl/fl pups according to
established protocols (Lichti et al., 2008). Cell-autonomous Adam17 deletion
was generated by transducing Adam17fl/fl keratinocytes with adenoviral Cre
(AdCre-IRES-GFP, Vector Biolabs) or adenoviral GFP as control (Ad-eGFP,
Vector Biolabs) at an MOI of 3. Notch overexpression was induced by
transduction with AdNICD.
SUPPLEMENTAL INFORMATION
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(reagents, microarray analysis, chromatin immunoprecipitations, and func-
tional assays), six figures, and two tables and can be found with this article
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